Explore more publications!
Healthcare Brief Comoros
Got News to Share?

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on December 10, 2025

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Dec. 10, 2025

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Indeterminate GlobeNewswire
Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome
Dec. 10, 2025

Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome

Indeterminate GlobeNewswire
GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique
Dec. 10, 2025

GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique

Indeterminate GlobeNewswire
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  
Dec. 10, 2025

GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy  

Indeterminate GlobeNewswire
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Dec. 10, 2025

Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®

Indeterminate GlobeNewswire
Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants
Dec. 10, 2025

Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants

Indeterminate GlobeNewswire
SuspendIt® Is Now a USP Verified Excipient
Dec. 10, 2025

SuspendIt® Is Now a USP Verified Excipient

Indeterminate GlobeNewswire
EmblemHealth Announces New Agreement with the Hospital for Special Surgery
Dec. 10, 2025

EmblemHealth Announces New Agreement with the Hospital for Special Surgery

Indeterminate GlobeNewswire
Cedarhurst Senior Living Fulfills More Than 50 Resident Dreams in 2025 Through Its Dream Come TRUE™ Program
Dec. 10, 2025

Cedarhurst Senior Living Fulfills More Than 50 Resident Dreams in 2025 Through Its Dream Come TRUE™ Program

Indeterminate GlobeNewswire
Priority Partners Opening Two More Free Mini-Pantries in Maryland
Dec. 10, 2025

Priority Partners Opening Two More Free Mini-Pantries in Maryland

Indeterminate GlobeNewswire
Changent Welcomes New Parent Ambassadors to Champion Families Nationwide
Dec. 10, 2025

Changent Welcomes New Parent Ambassadors to Champion Families Nationwide

Indeterminate GlobeNewswire
4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology
Dec. 10, 2025

4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology

Indeterminate GlobeNewswire
Uncloseted Media Expands Canadian Coverage and Secures Corporate Partnership with MISTR to Expand Healthcare Coverage
Dec. 10, 2025

Uncloseted Media Expands Canadian Coverage and Secures Corporate Partnership with MISTR to Expand Healthcare Coverage

Indeterminate GlobeNewswire
USOSM Surgeon Partners Gave 2,170+ Patients in Africa and Central America More Reasons to Smile through Medical Missions This Year
Dec. 10, 2025

USOSM Surgeon Partners Gave 2,170+ Patients in Africa and Central America More Reasons to Smile through Medical Missions This Year

Indeterminate GlobeNewswire
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
Dec. 10, 2025

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

Indeterminate GlobeNewswire
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership
Dec. 10, 2025

Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership

Indeterminate GlobeNewswire
CME Outfitters Awarded Joint Accreditation with Commendation, Recognizing Excellence in Interprofessional Continuing Education
Dec. 10, 2025

CME Outfitters Awarded Joint Accreditation with Commendation, Recognizing Excellence in Interprofessional Continuing Education

Indeterminate GlobeNewswire
Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina
Dec. 10, 2025

Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina

Indeterminate GlobeNewswire
Muscular Dystrophy Association Announces More Than $2.7 Million For Research Grants to Advance Breakthroughs Across Neuromuscular Diseases
Dec. 10, 2025

Muscular Dystrophy Association Announces More Than $2.7 Million For Research Grants to Advance Breakthroughs Across Neuromuscular Diseases

Indeterminate GlobeNewswire
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
Dec. 10, 2025

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions